Московский Научно-Исследовательский Институт Вакцин И Сывороток Им. И.И.Мечникова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский Научно-Исследовательский Институт Вакцин И Сывороток Им. И.И.МечниковаfiledCriticalМосковский Научно-Исследовательский Институт Вакцин И Сывороток Им. И.И.Мечникова
Priority to SU7402103989ApriorityCriticalpatent/SU511743A1/en
Application grantedgrantedCritical
Publication of SU511743A1publicationCriticalpatent/SU511743A1/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Description
0,25% фенола в готовом препарате с послеруюшим тшательным перемешиванием,0.25% of phenol in the finished product with post-dry tight mixing,
Готовый препарат контролирук т на полноту сорбции антигенов в реакции РТГПА.The finished product is controlled for completeness of sorption of antigens in the RTGPA reaction.
Claims (1)
Формула изобретени Invention FormulaСпособ получени ассоциированной вакцины путем обработки и ходкого материалаThe method of obtaining the associated vaccine by processing and salable materialформалином и последовательной сорбции на нос:ителе, отличающийс тем, что, с целью повыиюни иммуногенности препарате 13б}1аботку формалином осущест-Formalin and sequential sorption on the nose: Itele, characterized in that, прк комнатной температуре в течение 48-I5O ч, а сорбцию провод т из солевого раствора в следующей последовательности; prk room temperature for 48-I5O h, and the sorption is carried out from the salt solution in the following sequence;антиген из бактерий паратифа В, Флекснера,antigen from paratyphoid bacteria B, Flexner,паратифа А, Зонне, брюшного тифа, столбн чного анатоксина.paratyphoid A, Sonne, typhoid, tetanus toxoid.
SU7402103989A1974-12-231974-12-23Method of preparing associated vaccine
SU511743A1
(en)
PROCESS FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH ANTI-PARASITARY ACTION ON THE BASIS OF HALOGEN CONTAINING THE 2,2'-METHYLENE DIFENOL DERIVATIVES, AND METHOD FOR PREPARING THESE MEDICINAL COMPOUNDS.
PROCESS FOR PREPARING A PHARMACEUTICAL OR VETERINARY PREPARATION BASED ON PROSTAGLANDINE F & 012ALFA OR E & 012 ANALOGS, OBTAINED BY USE THEREOF, PREPARED PREPARATION, AND PROCESS FOR PREPARING THE PREPARATION OF PREPARATION.
PROCESS FOR PREPARING A PREPARATION FOR THE PREPARATION OF PLANT PATHOGENIC ORGANISMS, AND PROCESS FOR PREPARING 4,5 DIHYDRO-S-TRIAZOLO (4,3-A) QUINOLINE COMPOUNDS.